Newsroom

Serac Imaging Systems  announces that two posters featuring Seracam® are being presented by its academic partners from Loughborough University at the IEEE Nuclear Science Symposium, Medical Imaging Conference, taking place from 1-8 November 2025 in Yokohama, Japan. One displays the first presentation of Seracam®’s potential to prevent extravasation injury; the other introduces new features to enhance Seracam®’s capabilities in intraoperative imaging.

Serac Imaging Systems and its clinical investigators from the Faculty of Medicine at the University of Malaya, Malaysia, announce that an oral presentation evaluating the first clinical experience using Seracam® took place at the IUPESM World Congress on Medical Physics and Biomedical Engineering in Adelaide, Australia (29 September to 4 October).

Serac Imaging Systems Limited, the medtech company developing ‘Seracam®’ a portable hybrid gamma-optical camera for medical imaging, and its clinical investigators from The Ohio State University Wexner Medical Center, U.S., and the Faculty of Medicine at the University of Malaya, Malaysia, announce that posters featuring clinical trials directed using Seracam® are being presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting taking place from 21-24 June, 2025 in New Orleans, U.S.

Serac Life Sciences, the parent company of molecular imaging businesses Serac Imaging Systems Ltd and Serac Healthcare Ltd,  announce that their Scientific Advisor, Professor Alan Perkins, has been awarded a Member of the Order of the British Empire (MBE) in the King’s Birthday Honours in recognition of his outstanding services to patient care and clinical science.

The story of Seracam’s development from technology designed for outer space to the civil nuclear industry features in the April 2025 edition of Nuclear Engineering International.